FDA keeps access limited to Plan B morning-after pill

	Tweet

U.S. drug regulators kept the controversial morning-after pill behind the pharmacy counter as they denied the drugmaker’s request to drop the age limit on who can buy the emergency contraceptive without a prescription.

Health and Human Services Secretary Kathleen Sebelius on Wednesday directed the Food and Drug Administration to keep the prescription requirement for girls younger than 17.

She said the pill’s maker, Teva Pharmaceutical Industries Ltd, did not present enough evidence to show that younger girls would properly understand and use the pill, made to prevent unwanted pregnancies, without talking to a doctor first.

Although FDA Commissioner Margaret Hamburg signaled that she planned to approve Teva’s request, Sebelius’s disagreement led her to leave access to Teva’s Plan B One-Step limited.

The pill, which has to be taken within 72 hours of unprotected sexual intercourse, has technically been an over-the-counter drug, but only for women over 17. With younger girls requiring a prescription, buying Plan B has required showing a pharmacist identification for an age check.

(Reporting by Alina Selyukh in Washington)

###

(Reuters) -

RELATED STORIES:
Pill Among Least Effective Birth Control Methods   70 percent of women use contraceptives during their first sexual encounter   Long-term contraception more effective than pills   Gay couples and women over 40 to get free IVF treatment on NHS   Health secretary urges contraception compromise   Contraceptive ring, patch carry blood clot risks   Reminder Stamp Boosts HPV Vaccination   Study adds to evidence on clot risks of non-oral contraceptives   HPV vaccine completion rate among girls is poor, getting worse   Some ob-gyns cite religious conflicts over care   After IVF, some couples get pregnant without help   Web Tool Offers Map to Menopause   Early Menopause Could Also Mean Early Death   Does soy help cool hot flashes after all?   Caffeine not tied to worsening urinary incontinence

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]